nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxycycline—MMP13—leg—abdominal aortic aneurysm	0.0613	0.197	CbGeAlD
Doxycycline—MMP13—hindlimb—abdominal aortic aneurysm	0.0548	0.176	CbGeAlD
Doxycycline—MMP8—Matrix Metalloproteinases—TIMP4—abdominal aortic aneurysm	0.0451	0.0661	CbGpPWpGaD
Doxycycline—MMP1—leg—abdominal aortic aneurysm	0.0431	0.139	CbGeAlD
Doxycycline—MMP1—hindlimb—abdominal aortic aneurysm	0.0385	0.124	CbGeAlD
Doxycycline—MMP13—Matrix Metalloproteinases—TIMP4—abdominal aortic aneurysm	0.0329	0.0482	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—TIMP4—abdominal aortic aneurysm	0.0318	0.0466	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—TIMP4—abdominal aortic aneurysm	0.0254	0.0372	CbGpPWpGaD
Doxycycline—MMP1—artery—abdominal aortic aneurysm	0.0236	0.0758	CbGeAlD
Doxycycline—MMP8—blood plasma—abdominal aortic aneurysm	0.0227	0.073	CbGeAlD
Doxycycline—MMP8—Matrix Metalloproteinases—MMP14—abdominal aortic aneurysm	0.0149	0.0218	CbGpPWpGaD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—MMP14—abdominal aortic aneurysm	0.0141	0.0207	CbGpPWpGaD
Doxycycline—MMP13—connective tissue—abdominal aortic aneurysm	0.0134	0.0431	CbGeAlD
Doxycycline—MMP8—Collagen degradation—MMP14—abdominal aortic aneurysm	0.0123	0.0181	CbGpPWpGaD
Doxycycline—MMP8—connective tissue—abdominal aortic aneurysm	0.0121	0.0389	CbGeAlD
Doxycycline—MMP13—Matrix Metalloproteinases—MMP14—abdominal aortic aneurysm	0.0108	0.0159	CbGpPWpGaD
Doxycycline—MMP7—connective tissue—abdominal aortic aneurysm	0.0107	0.0343	CbGeAlD
Doxycycline—MMP7—Matrix Metalloproteinases—MMP14—abdominal aortic aneurysm	0.0105	0.0154	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—MMP14—abdominal aortic aneurysm	0.0103	0.0151	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—MMP14—abdominal aortic aneurysm	0.00995	0.0146	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—LRP1—abdominal aortic aneurysm	0.00963	0.0141	CbGpPWpGaD
Doxycycline—MMP1—connective tissue—abdominal aortic aneurysm	0.00943	0.0303	CbGeAlD
Doxycycline—MMP7—kidney—abdominal aortic aneurysm	0.0091	0.0292	CbGeAlD
Doxycycline—MMP13—Collagen degradation—MMP14—abdominal aortic aneurysm	0.00898	0.0132	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—MMP3—abdominal aortic aneurysm	0.00876	0.0129	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—MMP14—abdominal aortic aneurysm	0.00867	0.0127	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—MMP14—abdominal aortic aneurysm	0.00838	0.0123	CbGpPWpGaD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—MMP3—abdominal aortic aneurysm	0.00832	0.0122	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—MMP14—abdominal aortic aneurysm	0.00795	0.0117	CbGpPWpGaD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—LOX—abdominal aortic aneurysm	0.00793	0.0116	CbGpPWpGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—LOX—abdominal aortic aneurysm	0.00766	0.0112	CbGpPWpGaD
Doxycycline—MMP8—Collagen degradation—MMP3—abdominal aortic aneurysm	0.00725	0.0106	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—MMP14—abdominal aortic aneurysm	0.00693	0.0102	CbGpPWpGaD
Doxycycline—Minocycline—MMP9—abdominal aortic aneurysm	0.00688	1	CrCbGaD
Doxycycline—MMP13—Matrix Metalloproteinases—MMP3—abdominal aortic aneurysm	0.00639	0.00938	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP14—abdominal aortic aneurysm	0.00623	0.00914	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—MMP3—abdominal aortic aneurysm	0.00618	0.00906	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—MMP3—abdominal aortic aneurysm	0.00607	0.00891	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—MMP3—abdominal aortic aneurysm	0.00586	0.0086	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MMP14—abdominal aortic aneurysm	0.00577	0.00847	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MMP14—abdominal aortic aneurysm	0.00558	0.00818	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—MMP2—abdominal aortic aneurysm	0.00542	0.00795	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—LOX—abdominal aortic aneurysm	0.0054	0.00792	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—MMP3—abdominal aortic aneurysm	0.00529	0.00776	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—LOX—abdominal aortic aneurysm	0.00522	0.00765	CbGpPWpGaD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—MMP2—abdominal aortic aneurysm	0.00515	0.00755	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—LDLR—abdominal aortic aneurysm	0.00515	0.00755	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—MMP3—abdominal aortic aneurysm	0.00511	0.0075	CbGpPWpGaD
Doxycycline—SLC22A11—kidney—abdominal aortic aneurysm	0.00509	0.0164	CbGeAlD
Doxycycline—MMP1—Matrix Metalloproteinases—MMP3—abdominal aortic aneurysm	0.00494	0.00724	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP3—abdominal aortic aneurysm	0.00489	0.00717	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—NCF1—abdominal aortic aneurysm	0.00475	0.00697	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—MMP3—abdominal aortic aneurysm	0.00469	0.00688	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—NCF1—abdominal aortic aneurysm	0.00459	0.00674	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP14—abdominal aortic aneurysm	0.00455	0.00667	CbGpPWpGaD
Doxycycline—MMP8—Collagen degradation—MMP2—abdominal aortic aneurysm	0.00449	0.00658	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP14—abdominal aortic aneurysm	0.00439	0.00644	CbGpPWpGaD
Doxycycline—MMP1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—PTGS2—abdominal aortic aneurysm	0.00433	0.00635	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—ELN—abdominal aortic aneurysm	0.00427	0.00627	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—MMP3—abdominal aortic aneurysm	0.00424	0.00622	CbGpPWpGaD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—MMP3—abdominal aortic aneurysm	0.00412	0.00604	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—MMP3—abdominal aortic aneurysm	0.00409	0.00599	CbGpPWpGaD
Doxycycline—MMP8—Matrix Metalloproteinases—MMP9—abdominal aortic aneurysm	0.00408	0.00598	CbGpPWpGaD
Doxycycline—MMP1—Regulation of IGF Activity by IGFBP—MMP2—abdominal aortic aneurysm	0.00406	0.00596	CbGpPWpGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—MMP3—abdominal aortic aneurysm	0.00398	0.00583	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—LDLR—abdominal aortic aneurysm	0.00397	0.00583	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—MMP2—abdominal aortic aneurysm	0.00396	0.0058	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—SELL—abdominal aortic aneurysm	0.00389	0.00571	CbGpPWpGaD
Doxycycline—MMP8—Activation of Matrix Metalloproteinases—MMP9—abdominal aortic aneurysm	0.00387	0.00568	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—MMP2—abdominal aortic aneurysm	0.00382	0.0056	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—MMP2—abdominal aortic aneurysm	0.00376	0.00551	CbGpPWpGaD
Doxycycline—MMP1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKB1—abdominal aortic aneurysm	0.00376	0.00551	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP3—abdominal aortic aneurysm	0.00367	0.00539	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—MMP2—abdominal aortic aneurysm	0.00363	0.00532	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP14—abdominal aortic aneurysm	0.00351	0.00515	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—LDLR—abdominal aortic aneurysm	0.00347	0.00508	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—MMP3—abdominal aortic aneurysm	0.00344	0.00505	CbGpPWpGaD
Doxycycline—MMP8—Collagen degradation—MMP9—abdominal aortic aneurysm	0.00337	0.00495	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—MMP2—abdominal aortic aneurysm	0.00327	0.0048	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—MMP3—abdominal aortic aneurysm	0.00317	0.00465	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—MMP2—abdominal aortic aneurysm	0.00316	0.00464	CbGpPWpGaD
Doxycycline—CYP3A4—blood plasma—abdominal aortic aneurysm	0.00314	0.0101	CbGeAlD
Doxycycline—MMP13—Extracellular matrix organization—ELN—abdominal aortic aneurysm	0.00312	0.00457	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—MMP2—abdominal aortic aneurysm	0.00305	0.00448	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—ELN—abdominal aortic aneurysm	0.00301	0.00442	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—MMP9—abdominal aortic aneurysm	0.00297	0.00436	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SERPINE1—abdominal aortic aneurysm	0.00297	0.00435	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—LOX—abdominal aortic aneurysm	0.00296	0.00435	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—MMP2—abdominal aortic aneurysm	0.0029	0.00425	CbGpPWpGaD
Doxycycline—SLC22A8—kidney—abdominal aortic aneurysm	0.00287	0.00923	CbGeAlD
Doxycycline—MMP7—Matrix Metalloproteinases—MMP9—abdominal aortic aneurysm	0.00287	0.00421	CbGpPWpGaD
Doxycycline—MMP13—Activation of Matrix Metalloproteinases—MMP9—abdominal aortic aneurysm	0.00282	0.00414	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—MMP3—abdominal aortic aneurysm	0.00281	0.00412	CbGpPWpGaD
Doxycycline—MMP7—Activation of Matrix Metalloproteinases—MMP9—abdominal aortic aneurysm	0.00273	0.004	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—CDKN2A—abdominal aortic aneurysm	0.00273	0.004	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCL2—abdominal aortic aneurysm	0.00271	0.00398	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—MMP3—abdominal aortic aneurysm	0.00271	0.00397	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP3—abdominal aortic aneurysm	0.00268	0.00393	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—MMP3—abdominal aortic aneurysm	0.00266	0.0039	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP14—abdominal aortic aneurysm	0.00261	0.00383	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP3—abdominal aortic aneurysm	0.00259	0.0038	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP2—abdominal aortic aneurysm	0.00258	0.00379	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—MMP2—abdominal aortic aneurysm	0.00253	0.00371	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—MMP9—abdominal aortic aneurysm	0.00246	0.00361	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—NOS2—abdominal aortic aneurysm	0.00245	0.0036	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—ELN—abdominal aortic aneurysm	0.00241	0.00353	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—MMP9—abdominal aortic aneurysm	0.00238	0.00349	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—MMP9—abdominal aortic aneurysm	0.00238	0.00349	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—NOS2—abdominal aortic aneurysm	0.00237	0.00348	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—abdominal aortic aneurysm	0.00237	0.00347	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—MMP9—abdominal aortic aneurysm	0.0023	0.00337	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP2—abdominal aortic aneurysm	0.00227	0.00333	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—abdominal aortic aneurysm	0.00227	0.00333	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—CCL2—abdominal aortic aneurysm	0.00224	0.00329	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—MMP9—abdominal aortic aneurysm	0.00218	0.0032	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—LOX—abdominal aortic aneurysm	0.00216	0.00317	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MMP2—abdominal aortic aneurysm	0.00211	0.00309	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—SERPINE1—abdominal aortic aneurysm	0.00209	0.00307	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—LOX—abdominal aortic aneurysm	0.00209	0.00306	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP3—abdominal aortic aneurysm	0.00207	0.00303	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MMP2—abdominal aortic aneurysm	0.00203	0.00298	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—AGT—abdominal aortic aneurysm	0.00198	0.0029	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—abdominal aortic aneurysm	0.00194	0.00285	CbGpPWpGaD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—MMP9—abdominal aortic aneurysm	0.00191	0.00281	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP14—abdominal aortic aneurysm	0.0019	0.00279	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—MMP9—abdominal aortic aneurysm	0.0019	0.00279	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—MMP9—abdominal aortic aneurysm	0.0019	0.00279	CbGpPWpGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—MMP9—abdominal aortic aneurysm	0.00185	0.00271	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP14—abdominal aortic aneurysm	0.00184	0.0027	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—CCL2—abdominal aortic aneurysm	0.00173	0.00254	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP9—abdominal aortic aneurysm	0.00171	0.0025	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—LOX—abdominal aortic aneurysm	0.00167	0.00245	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP2—abdominal aortic aneurysm	0.00166	0.00243	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CCL2—abdominal aortic aneurysm	0.00163	0.00239	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—MMP9—abdominal aortic aneurysm	0.00162	0.00238	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—SERPINE1—abdominal aortic aneurysm	0.00161	0.00237	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP2—abdominal aortic aneurysm	0.0016	0.00235	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00158	0.00232	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MMP9—abdominal aortic aneurysm	0.00158	0.00232	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—NFKB1—abdominal aortic aneurysm	0.00157	0.0023	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP3—abdominal aortic aneurysm	0.00154	0.00226	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MMP9—abdominal aortic aneurysm	0.00153	0.00224	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—NFKB1—abdominal aortic aneurysm	0.00151	0.00222	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP14—abdominal aortic aneurysm	0.00147	0.00216	CbGpPWpGaD
Doxycycline—CYP3A4—kidney—abdominal aortic aneurysm	0.00142	0.00457	CbGeAlD
Doxycycline—MMP1—AP-1 transcription factor network—CDKN2A—abdominal aortic aneurysm	0.00142	0.00208	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—MMP9—abdominal aortic aneurysm	0.0013	0.00191	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP2—abdominal aortic aneurysm	0.00128	0.00188	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—MMP9—abdominal aortic aneurysm	0.00126	0.00185	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP9—abdominal aortic aneurysm	0.00125	0.00183	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—NFKB1—abdominal aortic aneurysm	0.00122	0.00179	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP9—abdominal aortic aneurysm	0.0012	0.00176	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—MMP9—abdominal aortic aneurysm	0.00117	0.00171	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP3—abdominal aortic aneurysm	0.00112	0.00165	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP3—abdominal aortic aneurysm	0.00108	0.00159	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SELL—abdominal aortic aneurysm	0.00105	0.00155	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—NFKB1—abdominal aortic aneurysm	0.00102	0.00149	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP9—abdominal aortic aneurysm	0.000962	0.00141	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP2—abdominal aortic aneurysm	0.000952	0.0014	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—P2RY12—abdominal aortic aneurysm	0.00095	0.00139	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—SERPINE1—abdominal aortic aneurysm	0.000934	0.00137	CbGpPWpGaD
Doxycycline—SLC22A11—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.000879	0.00129	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP3—abdominal aortic aneurysm	0.000867	0.00127	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP9—abdominal aortic aneurysm	0.000715	0.00105	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP2—abdominal aortic aneurysm	0.000694	0.00102	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—SERPINE1—abdominal aortic aneurysm	0.000681	0.001	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP2—abdominal aortic aneurysm	0.000671	0.000984	CbGpPWpGaD
Doxycycline—SLC22A8—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.000671	0.000984	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—SERPINE1—abdominal aortic aneurysm	0.000658	0.000965	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—NFKB1—abdominal aortic aneurysm	0.000623	0.000914	CbGpPWpGaD
Doxycycline—SLC22A6—SLC-mediated transmembrane transport—AAAS—abdominal aortic aneurysm	0.00056	0.000821	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP2—abdominal aortic aneurysm	0.000536	0.000786	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—SERPINE1—abdominal aortic aneurysm	0.000526	0.000772	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP9—abdominal aortic aneurysm	0.000522	0.000766	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP9—abdominal aortic aneurysm	0.000504	0.000739	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000447	0.000655	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP9—abdominal aortic aneurysm	0.000403	0.000591	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—NOS2—abdominal aortic aneurysm	0.000371	0.000545	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000341	0.0005	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—AGT—abdominal aortic aneurysm	0.00032	0.000469	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SERPINE1—abdominal aortic aneurysm	0.000313	0.000459	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—AAAS—abdominal aortic aneurysm	0.000284	0.000417	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CCL2—abdominal aortic aneurysm	0.000263	0.000386	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—MMP2—abdominal aortic aneurysm	0.000251	0.000368	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—AAAS—abdominal aortic aneurysm	3.74e-05	5.48e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—LDLR—abdominal aortic aneurysm	3.26e-05	4.79e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—AGT—abdominal aortic aneurysm	1.72e-05	2.53e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—APOE—abdominal aortic aneurysm	1.69e-05	2.48e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PTGS2—abdominal aortic aneurysm	1.16e-05	1.7e-05	CbGpPWpGaD
